Vnitřní lékařství, 1985 (roč. 31), číslo 8
[Congenital heart defects in adulthood].
I Riecanský, L Plachá, J Zelenay, K Havlínová, V Findo, I Simkovic, V Cornák
Vnitr Lek 1985, 31(8):729-735
[Post-exertional electromapping in the diagnosis of ischemic heart disease].
M Janota, V Brodan, J Lexa, J Stupka, J Fabián
Vnitr Lek 1985, 31(8):736-743
[Platelet alpha2-adrenergic receptors in essential hypertension. Methods of determining specific binding using (3H)-dihydroergocryptine and the effect of physical exertion].
P Prikryl, K Rysánek, V Vondrácek, J Prásek
Vnitr Lek 1985, 31(8):744-748
[Platelet alpha2-adrenergic receptors in essential hypertension. Number of binding sites, cyclic adenosine monophosphate and platelet aggregation].
P Prikryl, K Rysánek, V Vondrácek, M Penka, J Prásek, V Hrcková
Vnitr Lek 1985, 31(8):749-755
[Rheumatoid arthritis with antinuclear antibodies in the blood].
Z Pelísková, K Trnavský, J Vácha
Vnitr Lek 1985, 31(8):756-761
[The composition of skeletal muscle--an important factor in the pathogenesis of obesity in men].
K Vondra, D Urbanová, A Bass
Vnitr Lek 1985, 31(8):762-768
[The relation of amylase and endogenous creatinine clearance to kidney function].
J Racek, V Petríková
Vnitr Lek 1985, 31(8):769-774
[The HLA system and changes in thyroid hormones in patients].
V Felt, A Májský, P Herzog, V Vavrejnová, J Nedvídková
Vnitr Lek 1985, 31(8):775-781
[Use of the single-dimension echocardiographic examination (a scan) in the diagnosis of thyroid gland diseases. Comparison with scintigraphic and puncture findings].
V Brozková, J Smíd, F Cech, J Hůla, V Cepelák
Vnitr Lek 1985, 31(8):782-786
[Treatment of hypertension and ischemic heart disease].
J Widimský
Vnitr Lek 1985, 31(8):787-794
[Modern methods in the immunology of blood platelets].
P Korínková, A Májský
Vnitr Lek 1985, 31(8):795-801
[The relation of HLA to disease. What is the most reliable way to determine its significance?].
A Májský
Vnitr Lek 1985, 31(8):802-805
[At the present level of anticoagulation therapy with Pelentan, is it possible to expect effective prevention of thromboembolism?].
V Krislo, M Sorf, M Krislová
Vnitr Lek 1985, 31(8):806-809
[Treatment of ulcer disease using H2 antihistaminics].
L Vladár, F Hendrich, I Katuscák, R Hyrdel
Vnitr Lek 1985, 31(8):810-812